Essex Investment Management CO LLC Global Blood Therapeutics, Inc. Transaction History

Essex Investment Management CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$31.54 - $46.67 $436,040 - $645,212	-13,825 Closed	0 $0
Q3 2018 Oct 16, 2018	SELL	$38.0 - $51.1 $483,056 - $649,583	-12,712 Reduced 47.9%	13,825 $525,000
Q2 2018 Jul 17, 2018	BUY	$38.7 - $50.15 $677,520 - $877,976	17,507 Added 193.88%	26,537 $1.2 Million
Q1 2018 Apr 26, 2018	BUY	$39.6 - $65.9 $357,588 - $595,077	9,030 New	9,030 $436,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.